2022
DOI: 10.1016/j.cger.2022.05.008
|View full text |Cite
|
Sign up to set email alerts
|

Polypharmacy in the Homebound Population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 36 publications
0
1
0
Order By: Relevance
“…Current studies demonstrating an effect of the COVID-19 pandemic's decrease in ME cases focus on the primary care and hospital settings and are limited with respect to community pharmacies [28]. On the other hand, some studies have shown an increase in MEs, primarily in the elderly, due to the chronicity of their diseases, polypharmacy, and functional deterioration, which are aggravated by staying at home [29].…”
Section: Discussionmentioning
confidence: 99%
“…Current studies demonstrating an effect of the COVID-19 pandemic's decrease in ME cases focus on the primary care and hospital settings and are limited with respect to community pharmacies [28]. On the other hand, some studies have shown an increase in MEs, primarily in the elderly, due to the chronicity of their diseases, polypharmacy, and functional deterioration, which are aggravated by staying at home [29].…”
Section: Discussionmentioning
confidence: 99%
“…Adverse events related to medications in primary care contribute significantly to hospital admissions and mortality rates. Such events can arise from individuals experiencing adverse drug reactions, which are typically not preventable, or from medication errors, which are often preventable [9,10]. For all these reasons there are needed conditions to consider for polypharmacy to make sense beyond clinical practice guidelines [9].…”
Section: Political and Structural Measures To Improve The Use Of Medi...mentioning
confidence: 99%